R. Schreiber

R. Schreiber, G. Dunn, A. Bruce, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Up‐Regulation of Gamma Interferon Receptors on the Human Monocytic Cell Line U937 by 1,25‐Dihydroxyvitamin D3 and Granulocyte‐Macrophage Colony Stimulating Factor

R. Schreiber, S. Zuckerman, 1988, Journal of leukocyte biology.

The odds of immunotherapy success

R. Schreiber, M. Gubin, 2015, Science.

Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma.

R. Schreiber, A. Celada, Robert D. Schreiber, 1986, Journal of immunology.

BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigen.

Ansuman T. Satpathy, R. Schreiber, K. Murphy, 2022, Immunity.

Erratum: High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy (Cell (2018) 175(4) (1014–1030.e19), (S009286741831242X) (10.1016/j.cell.2018.09.030))

R. Fulton, C. Fronick, M. Fehlings, 2018 .

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Maxim N. Artyomov, R. Fulton, C. Fronick, 2018, Cell.

Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma.

P. Lacy, R. Schreiber, L. Falqui, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function1

R. Schreiber, P. Hertzog, M. Smyth, 2007, The Journal of Immunology.

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.

R. Schreiber, P. Monach, H. Schreiber, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Stimulation Cell Surface Antigen following IFN Cells in the Naive Mouse , but a Promiscuous Specific Marker of Type I IFN-Producing Bone Marrow Stromal Cell Antigen 2 Is a

R. Schreiber, M. Colonna, M. Cella, 2006 .

Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice

R. Schreiber, R. Crawford, M. Meltzer, 1993, Infection and immunity.

HIF-1 (cid:1) regulates epithelial inﬂammation by cell autonomous NF (cid:2) B activation and paracrine stromal remodeling

R. Schreiber, D. Hicklin, J. Arbeit, 2008 .

Anti–IFN-α/β Receptor Antibody Treatment Ameliorates Disease in Lupus-Predisposed Mice

R. Schreiber, D. Kono, A. Theofilopoulos, 2012, The Journal of Immunology.

Perforin and granzymes have distinct roles in defensive immunity and immunopathology.

R. Schreiber, M. Smyth, M. Degli-Esposti, 2006, Immunity.

Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling.

R. Schreiber, A. Celada, 1987, Journal of immunology.

Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo.

F. Chisari, R. Schreiber, H. Schlicht, 1994, Journal of immunology.

Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes.

R. Schreiber, A. Celada, P. Gray, 1985, The Journal of clinical investigation.

NKG2D–NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo

Olivia I. Koues, J. Payton, R. Schreiber, 2016, The Journal of Immunology.

Low-Grade B Cell Lymphoma In Vivo the Outgrowth of Naturally Arising NKG 2 D Ligand Interaction Inhibits − NKG 2

Olivia I. Koues, J. Payton, R. Schreiber, 2016 .

ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma.

R. Schreiber, S. Reddy, L. Platanias, 2001, The Journal of biological chemistry.

Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice.

V. Pasquetto, F. Chisari, R. Schreiber, 1997, Journal of immunology.

Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

E. Unanue, R. Schreiber, G. Bancroft, 1989, Journal of immunology.

Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes.

E. Unanue, M. Mcdaniel, R. Schreiber, 1993, Journal of immunology.

Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells

Bijal A. Parikh, R. Schreiber, Liping Yang, 2015, PLoS pathogens.

Leprosy: altered complement receptors in disseminated disease.

R. Schreiber, I. Gigli, F. Tausk, 1985, The Journal of investigative dermatology.

Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

R. Schreiber, M. Colonna, K. Murphy, 2009, The Journal of experimental medicine.

Ligand H60a Cancer Immunoediting of the NK Group 2D

R. Schreiber, J. Bui, D. Lacoursiere, 2022 .

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

D. Katz, R. Schreiber, A. Altman, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Stat-1 Is Not Essential for Inhibition of B Lymphopoiesis by Type I IFNs1

R. Schreiber, M. Cooper, R. Góngora, 2000, The Journal of Immunology.

Lymphopoiesis by Type I IFNs Stat-1 Is Not Essential for Inhibition of B

R. Schreiber, M. Cooper, R. Góngora, 2000 .

Strobl, Velmurugesan Arulampalam, A completely foreign receptor can mediate an interferon- g -like response

I. Kerr, R. Schreiber, P. Heinrich, 2022 .

Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection

M. Jordana, R. Schreiber, M. Mack, 2017, The Journal of experimental medicine.

Cytokine modulation of immune activation associated suppression of macrophage cyclooxygenase activity in vivo.

R. Schreiber, P. Needleman, K. Beckerman, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

Enumeration of cytokine‐secreting cells at the single‐cell level

R. Schreiber, J. Chiller, A. Glasebrook, 1989, European journal of immunology.

Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice

D. Goeddel, R. Schreiber, J. White, 2001, Science.

Macrophage I-A/I-E expression and macrophage-stimulating lymphokines in murine lupus.

R. Schreiber, R. Kofler, A. Theofilopoulos, 1984, Cellular immunology.

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

R. Schreiber, M. Vesely, 2013, Annals of the New York Academy of Sciences.

Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections

R. Schreiber, G. Zhong, E. Peterson, 1989, Infection and immunity.

A dual function of NKG2D ligands in NK‐cell activation

R. Schreiber, A. Shaw, L. Carayannopoulos, 2012, European journal of immunology.

Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor.

P. Lacy, R. Schreiber, J. Carel, 1993, Transplantation.

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.

L. Zitvogel, G. Kroemer, R. Schreiber, 2010, Cancer research.

In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies

R. Schreiber, R. Crawford, A. Fortier, 1992, Infection and immunity.

Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids.

R. Schreiber, J. Calderón, P. Leinikki, 1987, Journal of immunology.

The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1982, Clinical immunology and immunopathology.

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

D. Goeddel, R. Schreiber, F.J. Sauvage, 1994, Nature.

Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

E. Unanue, M. Diamond, Whitney E. Purtha, 2008, Science.

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

R. Schreiber, K. Murphy, T. Murphy, 2022, Nature Immunology.

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

R. Tisch, H. Mcdevitt, R. Schreiber, 1994, The Journal of experimental medicine.

Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development.

H. Mcdevitt, R. Schreiber, C. Jacob, 1992, International immunology.

Prevention of the graft-versus-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha.

R. Schreiber, A. Ammann, M. Shalaby, 1989, Transplantation.

Prolongation of Cardiac and Islet Allograft Survival by a Blocking Hamster Anti-Mouse CXCR3 Monoclonal Antibody

R. Schreiber, W. Hancock, Liqing Wang, 2008, Transplantation.

Chemokines upon Activation CXCL12 and Secrete Inflammatory to CXCR3 Ligands in the Presence of Cutting Edge: IFN-Producing Cells Respond

R. Schreiber, M. Colonna, M. Cella, 2002 .

Pharmacodynamics of cyclosporine.

R. Schreiber, P. Leinikki, N. Pellis, 1986, Transplantation Proceedings.

Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins

R. Schreiber, H. Bjornson, A. Bjornson, 1987, The Journal of experimental medicine.

Effect of antibodies directed against complement receptors on phagocytosis by polymorphonuclear leukocytes: use of iodination as a convenient measure of phagocytosis.

R. Schreiber, H. Ochs, P. Beatty, 1985, Journal of immunology.

Microenvironment and Immunology Transcription Factor NFATc 2 Controls the Emergence of Colon Cancer Associated with IL-6 – Dependent Colitis

Anna L. Brown, M. You, B. Tromberg, 2012 .

Role of Cytokines (Interleukin 1, Tumor Necrosis Factor, and Transforming Growth Factor 0) in Natural and Lipopolysaccharide-enhanced

R. Schreiber, T. MacVittie, R. Neta, 1991 .

Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB*

Yoshihiro Ohmori, Thomas A. Hamilton, Robert D. Schreiber, 1997, The Journal of Biological Chemistry.

Lack of an obligate role for IFN-gamma in the primary in vitro mixed lymphocyte response.

R. Schreiber, D. Hanto, R. P. Bucy, 1988, Journal of immunology.

Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection.

R. Schreiber, M. Colonna, Yaming Wang, 2012, Cell host & microbe.

Lymphokine regulation of macrophage effector activities.

R. Schreiber, R. Crawford, M. Meltzer, 1988, Advances in experimental medicine and biology.

Interferon-gamma-dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes.

R. Schreiber, R. Fox, I. Esparza, 1986, Journal of immunology.

Biosynthetic analysis of the human interferon-gamma receptor. Identification of N-linked glycosylation intermediates.

R. Schreiber, G. Hershey, 1989, The Journal of biological chemistry.

Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis.

E. Unanue, R. Schreiber, C. Tripp, 1994, Journal of immunology.

Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm

R. Schreiber, D. Portnoy, L. G. Tilney, 1989, The Journal of experimental medicine.

Validation of a role for endogenously produced IFN gamma in resolution of Listeria monocytogenes infection in mice.

R. Schreiber, 1988, Advances in experimental medicine and biology.

Receptor on Human Mononuclear Phagocytes

R. Schreiber, A. Celada, R. Allen, 1985 .

The biology and biochemistry of interferon-gamma and its receptor

M. Farrar, R. Schreiber, 1993, Gastroenterologia Japonica.

Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling

R. Schreiber, C. Ng, M. Oldstone, 2013, Science.

Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4

S. Szabo, J. Darnell, R. Schreiber, 1995, The Journal of experimental medicine.

Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

E. Unanue, R. Schreiber, L. Brunt, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Purification and characterization of the human interferon-gamma receptor from placenta.

R. Schreiber, M. Thomas, K. Sheehan, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor

D. Katz, R. Schreiber, A. Altman, 1982, The Journal of experimental medicine.

Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1981, The Journal of experimental medicine.

Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1980, Journal of immunology.

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1977, The Journal of experimental medicine.

Deficiency of erythrocyte C3b receptor (CR1) in AIDS and AIDS-related syndromes

R. Schreiber, J. McCutchan, I. Gigli, 1986, Bioscience reports.

Interleukin-10 Receptor Signaling through the JAK-STAT Pathway

S. Akira, R. Schreiber, K. Takeda, 1999, The Journal of Biological Chemistry.

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.

G. Stark, R. Schreiber, C. Ramana, 2002, Trends in immunology.

Tissue-specific targeting of cytokine unresponsiveness in transgenic mice.

R. Schreiber, S. Gordon, D. Greaves, 1995, Immunity.

Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

R. Schreiber, N. Buchmeier, 1985, Proceedings of the National Academy of Sciences of the United States of America.

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Evan W. Newell, Maxim N. Artyomov, Robert D. Schreiber, 2018, Cell.

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

R. Schreiber, C. Milliman, G. Núñez, 1990, Nature.

Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.

R. Schreiber, M. McElrath, K. Squires, 1989, Journal of immunology.

Cutting Edge: IFN-Producing Cells Respond to CXCR3 Ligands in the Presence of CXCL12 and Secrete Inflammatory Chemokines upon Activation1

Ravindra Uppaluri, Brigitte G. Dorner, Kathleen C. F. Sheehan, 2002, The Journal of Immunology.

The roles of IFNγ in protection against tumor development and cancer immunoediting

Lloyd J. Old, Hiroaki Ikeda, Robert D. Schreiber, 2002 .

The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Hiroaki Ikeda, R. Schreiber, H. Ikeda, 2002, Cytokine & growth factor reviews.

IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors1

R. Schreiber, L. Lanier, L. Carayannopoulos, 2006, The Journal of Immunology.

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

J. Darnell, R. Schreiber, J. Bromberg, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Cancer Immunosurveillance: Immunoediting

R. Schreiber, D. Lussier, 2016 .

Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

Sami Al-Hajjar, H. Al-Rayes, J. Casanova, 2003, Nature genetics.

Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency

Sami Al-Hajjar, H. Al-Rayes, J. Casanova, 2003, Nature Genetics.

Molecular biology and chemistry of the alternative pathway of complement.

R. Schreiber, H. Müller-Eberhard, Robert D. Schreiber, 1980, Advances in immunology.

Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function

R. Schreiber, O. Götze, H. Müller-Eberhard, 1976, The Journal of experimental medicine.

THE RENAISSANCE OF CANCER IMMUNOSURVEILLANCE IFN-γ , Perforin , and Lymphocytes in Tumor

R. Schreiber, G. Dunn, L. Old, 2004 .

Interferon-γ and cancer immunoediting

R. Schreiber, G. Dunn, A. Bruce, 2005 .

Type I interferons are essential mediators of apoptotic death in virally infected cells

T. Taniguchi, R. Schreiber, E. Oda, 1998, Genes to cells : devoted to molecular & cellular mechanisms.

CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion.

R. Schreiber, M. Bevan, J. Harty, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Enumeration andCharacterization of Human Killer and Natural Killer Cells by a Modified Single‐Cell Assay

R. Schreiber, H. Müller-Eberhard, P. Perlmann, 1984, Scandinavian journal of immunology.

Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity

R. Schreiber, H. Müller-Eberhard, P. Perlmann, 1981, The Journal of experimental medicine.

Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation

R. Schreiber, R. Mitchell, I. Verma, 1985, Cell.

Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice

R. Schreiber, L. Old, E. Stockert, 1998 .

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.

R. Schreiber, L. Old, E. Stockert, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

R. Schreiber, L. Old, A. Dighe, 1994, Immunity.

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor

R. Schreiber, H. Müller-Eberhard, R. Medicus, 1975, The Journal of experimental medicine.

C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.

R. Schreiber, H. Müller-Eberhard, P. Perlmann, 1983, Journal of immunology.

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Mark J. Smyth, Robert D. Schreiber, R. Schreiber, 2012, The Journal of experimental medicine.

Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

R. Schreiber, H. Ikeda, L. Old, 2000, Immunity.

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

M. Delorenzi, L. Pusztai, L. Zitvogel, 2014, Nature Medicine.

Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

R. Schreiber, N. Cooper, D. Beebe, 1983, Journal of immunology.

A critical function for type I interferons in cancer immunoediting

R. Schreiber, G. Dunn, A. Bruce, 2005, Nature Immunology.

Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance.

T. Ley, J. Payton, R. Schreiber, 2009, Cancer research.

Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.

R. Schreiber, 1984, Contemporary topics in immunobiology.

Production of antigen-nonspecific immunoregulatory lymphokines by T cell hybridomas.

D. Katz, R. Schreiber, A. Altman, 1982, Current topics in microbiology and immunology.

Interferon-gamma induces receptor dimerization in solution and on cells.

D. Goeddel, R. Schreiber, D. Pennica, 1993, The Journal of biological chemistry.

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

F. Chisari, R. Schreiber, T. Ishikawa, 1996, Immunity.

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

F. Chisari, R. Schreiber, H. Schlicht, 1993, The Journal of experimental medicine.

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon‐γ

F. Chisari, R. Schreiber, R. Ulevitch, 1992 .

Studies on antibodies directed toward single antigenic sites on globular proteins.

R. Schreiber, M. Reichlin, R. Noble, 1972, Biochemistry.

Critical Role for Interferon Regulatory Factor 3 (IRF-3) and IRF-7 in Type I Interferon-Mediated Control of Murine Norovirus Replication

Larissa B. Thackray, M. Diamond, R. Schreiber, 2012, Journal of Virology.

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis

S. Akira, R. Schreiber, M. Smyth, 2008, Proceedings of the National Academy of Sciences.

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

Deepak Mittal, R. Schreiber, M. Smyth, 2014, Current opinion in immunology.

Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection.

R. Schreiber, G. Dunn, A. Bruce, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

R. Schreiber, K. Murphy, G. Dunn, 2011, The Journal of experimental medicine.

Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway

R. Schreiber, S. Rodig, R. DuBois, 1996, Cell.

Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor.

M. Farrar, R. Schreiber, J. Campbell, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Functional Cooperation of the Interleukin-2 Receptor β Chain and Jak1 in Phosphatidylinositol 3-Kinase Recruitment and Phosphorylation

W. Leonard, R. Schreiber, M. Berg, 1998, Molecular and Cellular Biology.

BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4 T cell responses to persistent antigen

Ansuman T. Satpathy, R. Schreiber, K. Murphy, 2021, bioRxiv.

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

Paul J Hertzog, Donald Metcalf, Warren S Alexander, 2006, Nature Immunology.

Compensatory dendritic cell development mediated by BATF-IRF interactions

Michael S. Behnke, Ansuman T. Satpathy, L. Sibley, 2012, Nature.

CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes.

Mark J. Miller, E. Unanue, R. Schreiber, 2011, Immunity.

Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma

Dariusz Przybylski, R. Schreiber, N. Marjanovic, 2017, Oncotarget.

The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.

R. Schreiber, J. Ward, M. Gubin, 2016, Advances in immunology.

Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity.

E. Unanue, R. Schreiber, D. Chaplin, 1988, Journal of immunology.

MHC-II neoantigens shape tumor immunity and response to immunotherapy

Cheryl F. Lichti, E. Unanue, T. Jacks, 2019, Nature.

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer

T. Vickery, R. Schreiber, T. Fleming, 2021, medRxiv.

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

M. Fehlings, R. Schreiber, E. Newell, 2017, Nature Communications.

Adaptive immunity maintains occult cancer in an equilibrium state

Lloyd J. Old, Mark J. Smyth, Robert D. Schreiber, 2007, Nature.

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

R. Cardiff, D. Levy, M. Welch, 2012, Breast Cancer Research.

Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma

Erica K. Barnell, Zachary L. Skidmore, R. Fulton, 2022, medRxiv.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape

E. Mardis, R. Schreiber, A. Korman, 2017, Cancer Immunology Research.

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

Jack D Bui, R. Schreiber, Robert D Schreiber, 2007, Current opinion in immunology.

CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

E. Klechevsky, M. Pellegrini, A. Sette, 2023, Science.

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

S. Akira, H. Kuwata, R. Schreiber, 2003, The Journal of clinical investigation.

Immune‐mediated dormancy: an equilibrium with cancer

R. Schreiber, M. Smyth, J. Swann, 2008, Journal of leukocyte biology.

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

R. Schreiber, J. Parker, H. Thomas, 1998, The Journal of clinical investigation.

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.

R. Schreiber, C. Hsieh, R. Uppaluri, 2006, Cancer research.

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

Maxim N. Artyomov, E. Unanue, C. Fronick, 2020, Cell.

Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins

R. Schreiber, H. Müller-Eberhard, D. Morrison, 1979, The Journal of experimental medicine.

Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.

R. Schreiber, N. Cooper, A. Sobel, 1979, Journal of immunology.

Vav proteins control MyD88-dependent oxidative burst.

R. Xavier, R. Schreiber, W. Swat, 2007, Blood.

The molecular cell biology of interferon-gamma and its receptor.

M. Farrar, R. Schreiber, R D Schreiber, 1993, Annual review of immunology.

FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE

R. Schreiber, H. Müller-Eberhard, 1974, The Journal of experimental medicine.

Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse

E. Unanue, R. Schreiber, G. Bancroft, 1991, Immunological reviews.

Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.

W. J. Johnson, R. Schreiber, D. Adams, 1983, Journal of immunology.

Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes.

R. Schreiber, R. Green, I. Esparza, 1983, Journal of immunology.

An Important Role for CD4+ T Cells in Adaptive Immunity to Toxoplasma gondii in Mice Lacking the Transcription Factor Batf3

Michael S. Behnke, L. Sibley, R. Schreiber, 2020, mSphere.

Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses

R. Schreiber, Eugene M. Johnson, S. Rodig, 1998, Cell.

Consensus nomenclature for CD 8 T cell phenotypes in cancer

S. H. van der Burg, J. Blay, F. Marincola, 2015 .

A molecular concept of the properdin pathway.

R. Schreiber, O. Götze, H. Müller-Eberhard, 1976, Proceedings of the National Academy of Sciences of the United States of America.

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.

R. Schreiber, G. Dunn, L. Old, 2005, Cancer research.

Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment

R. Schreiber, R. Faccio, S. Chan, 2016, Oncotarget.

Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα+ tumorigenesis

R. Schreiber, J. White, W. Vermi, 2013, Cell Death and Differentiation.

DNA double strand breaks activate a multi-functional genetic program in developing lymphocytes

B. Helmink, R. Schreiber, R. Paules, 2008, Nature.

Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1980, Clinical immunology and immunopathology.

Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins

R. Schreiber, H. Müller-Eberhard, Robert D. Schreiber, 1978, The Journal of experimental medicine.

The molecular basis of IFN? action

R. Schreiber, E. Bach, A. Greenlund, 1997 .

The IFN gamma receptor: a paradigm for cytokine receptor signaling.

M Aguet, R. Schreiber, M. Aguet, 1997, Annual review of immunology.

and shape tumour immunogenicity

Lloyd J. Old, Hiroaki Ikeda, Paul E. Swanson, 2001 .

Stat1-independent regulation of gene expression in response to IFN-γ

Richard M. Ransohoff, Chilakamarti V. Ramana, Robert D. Schreiber, 2001, Proceedings of the National Academy of Sciences of the United States of America.

ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ*

S. Roy, R. Schreiber, S. Reddy, 2001, The Journal of Biological Chemistry.

A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

S. Dorman, A. Fischer, R. Döffinger, 1999, Nature Genetics.

Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent

R. Cardiff, R. Schreiber, A. Borowsky, 2015, PloS one.

Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.

J. Casanova, R. Schreiber, M. Levin, 1997, The Journal of clinical investigation.

Activation of the alternative and classical complement pathways by Entamoeba histolytica

R. Schreiber, J. Calderón, 1985, Infection and immunity.

Identification of the activator system for antibody to Toxoplasma as the classical complement pathway.

R. Schreiber, H. Feldman, 1980, The Journal of infectious diseases.

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

R. Schreiber, J. Sissons, M. Oldstone, 1980, Proceedings of the National Academy of Sciences of the United States of America.

NF-kappa B-inducing kinase regulates selected gene expression in the Nod2 signaling pathway.

D. Goeddel, Shuang Huang, R. Schreiber, 2006, Infection and immunity.

Cytokine Signaling in 2002 New Surprises in the Jak/Stat Pathway

Massimo Gadina, R. Schreiber, J. O’Shea, 2002, Cell.

Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection.

S. Pestka, R. Döffinger, J. Casanova, 2000, The Journal of infectious diseases.

Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation

Steven M. Holland, Robert D. Schreiber, Catherine Dargemont, 2001, Science.

Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease

J. Casanova, R. Schreiber, C. Picard, 2006, PLoS genetics.

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

R. Schreiber, N. Cooper, J. Mayes, 1984, The Journal of clinical investigation.

Cancer Immunoediting of the NK Group 2D Ligand H60a

R. Schreiber, G. Dunn, Timothy E. O’Sullivan, 2011, The Journal of Immunology.

A completely foreign receptor can mediate an interferon‐γ‐like response

I. Kerr, R. Schreiber, P. Heinrich, 2001 .

Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.

R. Schreiber, D. Piwnica-Worms, K. Luker, 2001, Cancer research.

CHAPTER 24 – Interferon-γ

R. Schreiber, G. Schreiber, 2003 .

Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity.

R. Schreiber, Elise Alspach, D. Lussier, 2019, Cold Spring Harbor perspectives in biology.

STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-α in the central nervous system

Iain L. Campbell, Robert D. Schreiber, R. Schreiber, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of IFN‐α/β genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN‐α/β

T. Taniguchi, R. Schreiber, C. Schindler, 1996, Genes to cells : devoted to molecular & cellular mechanisms.

Biologic consequences of Stat1-independent IFN signaling

Chilakamarti V. Ramana, Robert D. Schreiber, G. Stark, 2001, Proceedings of the National Academy of Sciences of the United States of America.

IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response1

R. Schreiber, P. Allen, H. Ikeda, 2005, The Journal of Immunology.

A Temporal Role Of Type I Interferon Signaling in CD8+ T Cell Maturation during Acute West Nile Virus Infection

M. Diamond, R. Schreiber, K. Murphy, 2011, PLoS pathogens.

Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting.

R. Schreiber, Robert D Schreiber, 2005, Cancer immunity.

A role for the immunological synapse in lineage commitment of CD4 lymphocytes

Roberto A. Maldonado, D. Irvine, R. Schreiber, 2004, Nature.

Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway

R. Schreiber, J. Altman, R. Ahmed, 1999, Nature Medicine.

Cancer immunoediting: from immuno- surveillance to tumor escape

R. Schreiber, G. Dunn, A. Bruce, 2002 .

Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.

R. Schreiber, K. Sheehan, J. Calderón, 1988, Journal of immunology.

IL-12 Stimulates Interferon-Gamma Mediated Inhibition of Tumor-Induced Regulatory T Cell Proliferation and Enhances Tumor Clearance

T. Ley, R. Schreiber, D. Piwnica-Worms, 2008 .

Agents in Breast Cancer Cells Overexpression of IRF 9 Confers Resistance to Antimicrotubule Updated Version

R. Schreiber, D. Piwnica-Worms, K. Luker, 2001 .

Overexpression of IRF 9 Confers Resistance to Antimicrotubule Agents in Breast Cancer Cells 1

R. Schreiber, D. Piwnica-Worms, K. Luker, 2001 .

A Novel c-Jun-dependent Signal Transduction Pathway Necessary for the Transcriptional Activation of Interferon γ Response Genes*

R. Schreiber, J. Trapani, K. Sabapathy, 2007, Journal of Biological Chemistry.

Identification of an Interferon- Receptor Chain Sequence Required for JAK-1 Binding (*)

R. Schreiber, A. Shaw, J. Tanner, 1996, The Journal of Biological Chemistry.

Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state.

R. Schreiber, M. Smyth, H. Duret, 2012, Cancer research.

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

D. Goeddel, R. Schreiber, L. Wu, 2001, Science.

The chemistry and biology of complement receptors

R. Schreiber, 1984, Springer Seminars in Immunopathology.

Loss of DAP12 and FcRγ Drives Exaggerated IL-12 Production and CD8+ T Cell Response by CCR2+ Mo-DCs

Mark J. Miller, M. Diamond, R. Schreiber, 2013, PloS one.

Origins Progressively Growing versus Rejecting Tumors of Similar Comparative Analysis of Regulatory and Effector T Cells in Updated

R. Schreiber, C. Hsieh, R. Uppaluri, 2006 .

The role of c3 fragments in polymorphonuclear leukocyte (PMN) mediated cytocidal reactions

R. Schreiber, M. Pangburn, A. Bjornson, 1982 .

Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection

M. Diamond, R. Schreiber, Helen M. Lazear, 2015, PloS one.

Breaking down the barriers to cancer immunotherapy

E. Puré, R. Schreiber, J. Allison, 2005, Nature Immunology.

Response to 'A cancer immunosurveillance controversy'

R. Schreiber, A. Hayday, L. Old, 2004, Nature Immunology.

IFNγ Receptor-STAT1 Signaling and Cancer Immunoediting

R. Schreiber, G. Dunn, L. Old, 2003 .

Signaling and signaling dysfunction through the interferon gamma receptor.

R. Schreiber, L. Old, V. Shankaran, 1998, European cytokine network.

Ligand-induced assembly and activation of the gamma interferon receptor in intact cells

R. Schreiber, S. Marsters, A. Ashkenazi, 1996, Molecular and cellular biology.

Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.

K. Okuno, R. Schreiber, P. Greenberg, 1989, Journal of immunology.

Characterization and expression of the human leukocyte-common antigen (CD45) gene contained in yeast artificial chromosomes.

R. Schreiber, B. Brownstein, M. Thomas, 1991, Genomics.

Stat3 Recruitment by Two Distinct Ligand-induced, Tyrosine-phosphorylated Docking Sites in the Interleukin-10 Receptor Intracellular Domain*

J. Darnell, R. Schreiber, J. Riley, 1996, The Journal of Biological Chemistry.

A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child.

A. Fischer, J. Casanova, R. Schreiber, 1998, American journal of human genetics.

Suppression of ACTH-induced steroidogenesis by supernatants from LPS-treated peritoneal exudate macrophages.

R. Schreiber, R. Ulevitch, J. Mathison, 1983, Journal of immunology.

In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.

R. Schreiber, T. Ulich, E. Fernandez-cruz, 1985, Journal of immunology.

Nephritic Factor: Its Structure and Function and Its Relationship to Initiating Factor of the Alternative Pathway

R. Schreiber, O. Götze, H. Müller-Eberhard, 1976, Scandinavian journal of immunology.

Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody

R. Schreiber, N. Cooper, H. Müller-Eberhard, 1979, The Journal of experimental medicine.

Lipopolysaccharide-dependent induction of IL-10 receptor expression on murine fibroblasts.

R. Schreiber, R M Weber-Nordt, M A Meraz, 1994, Journal of immunology.

Ligand-Induced Autoregulation of IFN-γ Receptor β Chain Expression in T Helper Cell Subsets

S. Szabo, R. Schreiber, K. Murphy, 1995, Science.

TAK1 targeting by glucocorticoids determines JNK and IkappaB regulation in Toll-like receptor-stimulated macrophages.

R. Schreiber, L. Muglia, M. Colonna, 2010, Blood.

Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat.

R. Schreiber, R. Didlake, B. Kahan, 1988, Transplantation.

Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain.

R. Schreiber, S. Marsters, A. Ashkenazi, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Ligand-induced Formation of p55 and p75 Tumor Necrosis Factor Receptor Heterocomplexes on Intact Cells*

R. Schreiber, K. Sheehan, J. Pinckard, 1997, The Journal of Biological Chemistry.

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75

D. Goeddel, R. Schreiber, C. Arthur, 1995, The Journal of experimental medicine.

Monoclonal Antibodies Specific for Murine p55 and p75 Tumor Necrosis Factor Receptors: Identification of a Novel In Vivo Role for p75 By Kathleen C. F. Sheehan, J. Keith Pinckard, Cora D. Arthur,

D. Goeddel, R. Schreiber, L. Dehner, 1995 .

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

R. Schreiber, M. Colonna, Yaming Wang, 2011, The Journal of experimental medicine.

HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling.

R. Schreiber, D. Hicklin, J. Arbeit, 2008, Blood.

C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1983, Journal of immunology.

Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.

R. Schreiber, M. Meltzer, A. Fortier, 1985, Journal of immunology.

Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma

Christopher A. Miller, E. Mardis, R. Perrin, 2019, Oncoimmunology.

Brief Definitive Report Plasmacytoid Dendritic Cell Numbers in Vivo

R. Schreiber, M. Colonna, Yaming Wang, 2022 .

Programmable nanoparticle functionalization for in vivo targeting

R. Schreiber, P. Schlesinger, G. Hu, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer

C. Dence, T. Sharp, M. Welch, 2012, The Journal of Nuclear Medicine.

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

R. Schreiber, I. Gigli, F. Tausk, 1986, The Journal of clinical investigation.

The role of antibody and complement in lysing virus-infected cells

R. Schreiber, J. Sissons, N. Cooper, 2005, Medical Microbiology and Immunology.

LYSIS OF MEASLES VIRUS-INFECTED CELLS BY THE PURIFIED CYTOLYTIC ALTERNATIVE C O M P L E M E N T PATHWAY AND ANTIBODY*

R. Schreiber, J. Sissons, N. Cooper, 2003 .

Comparison of Five Short‐Term Assays That Measure Nonspecific Cytotoxicity Mediated to Tumor Cells by Activated Macrophages

R. Schreiber, E. Akporiaye, S. Russell, 1986, Journal of leukocyte biology.

The role of interferon-gamma in the induction of activated macrophages.

R. Schreiber, A. Celada, N. Buchmeier, 1986, Annales de l'Institut Pasteur. Immunologie.

Molecular characterization of macrophage activating factor for tumor cytotoxicity

R. Schreiber, 1985 .

Response to interferons and antibacterial innate immunity in the absence of tyrosine‐phosphorylated STAT1

G. Stark, R. Schreiber, C. Schindler, 2016, EMBO reports.

Measurement of Mouse and Human Interferon γ

R. Schreiber, Robert D. Schreiber, 2000, Current protocols in immunology.

IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.

R. Schreiber, P. Allen, H. Ikeda, 2005, Journal of immunology.

Toll-like receptor-dependent production of IL-12 p 40 causes chronic enterocolitis in myeloid cell-specific Stat 3-deficient mice

S. Akira, H. Kuwata, R. Schreiber, 2003 .

IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections.

R. Schreiber, C. Nacy, D. Leiby, 1993, Microbial pathogenesis.

C3 modified at the thiolester site: Acquisition of reactivity with cellular C3b receptors

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1981, Bioscience reports.

Ligand-induced phosphorylation of the human interferon-gamma receptor. Dependence on the presence of a functionally active receptor.

R. Schreiber, D. McCourt, G. Hershey, 1990, The Journal of biological chemistry.

Suppression and Promotion Cancer Immunoediting : Integrating Immunity ' s Roles in Cancer

R. Schreiber, L. Old, M. Smyth, 2014 .

Experimental variables for induction of activated cytotoxic macrophages.

R. Schreiber, M. Meltzer, D. Hoover, 1986, Annales de l'Institut Pasteur. Immunologie.

Immunology at 2000.

E. Unanue, R. Schreiber, K. Murphy, 1999, Immunity.

Macrophage activation: synergism between hybridoma MAF and poly(I). Poly(C) delivered by liposomes.

R. Schreiber, R. Schultz, C. Pidgeon, 1983, Journal of immunology.

Improving antibodies by evolution and engineering

R. Schreiber, G. Dunn, A. Bruce, 2003 .

cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1.

R. Schreiber, K. Murphy, T. Murphy, 2022, Cancer immunology research.

Constitutive shedding of both p55 and p75 murine TNF receptors in vivo.

R. Schreiber, C. Arthur, K. Sheehan, 1997, Journal of immunology.

CHAPTER 24 – Interferon-γ

R. Schreiber, G. Schreiber, 2003 .

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

R. Tisch, H. Mcdevitt, R. Schreiber, 1994, The Journal of experimental medicine.

Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

R. Schreiber, K. Murphy, Kevin W. O’Connor, 2021, The Journal of Immunology.

The structure and function of interferon-γ receptors

M. Farrar, R. Schreiber, J. Fernández-Luna, 1992 .

The Molecular and Cellular Biology of the IFNγ Receptor

R. Schreiber, P. Gray, G. Hershey, 1989 .

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

R. Cardiff, D. Levy, R. Schreiber, 2012, Breast Cancer Research.

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma.

F. Chisari, R. Schreiber, P. Gilles, 1992, Hepatology.

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

R. Schreiber, A. Altman, S. Russell, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor

R. Schreiber, T. Springer, D. Beller, 1982, The Journal of experimental medicine.

New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

R. Schreiber, M. Smyth, D. Mittal, 2014, Current opinion in immunology.

Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity

E. Unanue, M. Diamond, Whitney E. Purtha, 2008, Science.

Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4

S. Szabo, J. Darnell, R. Schreiber, 1995, The Journal of experimental medicine.

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

S. Akira, H. Kuwata, R. Schreiber, 2003, The Journal of clinical investigation.

Molecular Interactions of the Control Proteins C3b Inactivator and β1H with Various Complement Intermediates

R. Schreiber, M. Pangburn, H. Müller-Eberhard, 1978, The Journal of Immunology.

High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy

Maxim N. Artyomov, R. Fulton, C. Fronick, 2018, Cell.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape

E. Mardis, R. Schreiber, A. Korman, 2017, Cancer Immunology Research.

CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.

M. Pittman, R. Schreiber, J. Lewis, 2011, Cancer research.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Molecular Cancer Therapeutics.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Molecular Cancer Research.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Cancer immunology research.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Blood Cancer Discovery.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Cancer Epidemiology, Biomarkers and Prevention.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Clinical Cancer Research.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Cancer Prevention Research.

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.

E. Mardis, M. Loda, K. Flaherty, 2022, Cancer Research.

Restriction of heterogeneity of goat antibodies specific for human hemoglobin SS.

R. Schreiber, M. Reichlin, R. Noble, 1975, Journal of immunology.

Abstract 526: Cancer immunoediting by the innate immune system in the absence of adaptive immunity

R. Schreiber, W. Vermi, Timothy E. O’Sullivan, 2012 .

Analysis of deficiencies in IFN-gamma-mediated priming for tumor cytotoxicity in peritoneal macrophages from A/J mice.

R. Schreiber, A. Celada, T. Hamilton, 1986, Journal of Immunology.

A pilot trial of neoantigen DNA vaccine in combination with nivolumab/ipilimumab and prostvac in metastatic hormone-sensitive prostate cancer (mHSPC).

R. Schreiber, V. Arora, J. Picus, 2021 .